glp-1 prescriptions growth slowing 2024 The trend: What the real-world data reveals Glucagon-like peptide-1 receptor: mechanisms and

Produced by specialised intestinal cells, GLP-1 stimulates insulin secretion, suppresses glucagon, slows gastric emptying, and promotes satiety

This increased risk may have limited the enthusiasm for testing GLP1RAs against AUD, as patients with AUD are already at higher risk for pancreatitis and pancreatic cancer [92]

These results demonstrate that a 1.5-mg dose of dulaglutide is superior to insulin glargine, and that a 0.75-mg dose of dulaglutide is noninferior to insulin glargine94)

The result was a way of eating that finally felt safe again

May your doses stay optimal, your side effects stay manageable, and your results stay sustainable